Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Taysha Gene Therapies Taysha Gene Therapies Added to the Nasdaq Biotechnology Index December 15, 2021 From Taysha Gene Therapies Via Business Wire Tickers TSHA Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update November 10, 2021 From Taysha Gene Therapies Via Business Wire Tickers TSHA Taysha Gene Therapies Announces Publication of Positive Proof-of-Concept Preclinical Data for an AAV-mediated UBE3A Gene Replacement Approach Demonstrating Therapeutic Potential for The Treatment of Angelman Syndrome in the Journal JCI Insight October 25, 2021 From Taysha Gene Therapies Via Business Wire Tickers TSHA Taysha Announces Exclusive Option from UTSW to License Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program for CLN7 Disease, a Research Collaboration with UTSW to Develop Next-Generation Construct for CLN7 and a Grant Award to Batten Hope October 05, 2021 From Taysha Gene Therapies Via Business Wire Tickers TSHA Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update August 16, 2021 From Taysha Gene Therapies Via Business Wire Tickers TSHA Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.